Lenire
FDA approved Tinnitus Treatment Device

How does it work?
With these advanced features of the Lenire device, you’ll be able to say goodbye to those frustrating and persistent tinnitus symptoms and get back to hearing the life you love!
Clinical Trials and Success Rates
Based on the TENT-A2 clinical trial involving 191 patients, 95% of compliant TENT-A2 participants reported a clinically significant improvement their tinnitus symptom severity after 12 weeks of treatment. When evaluated at 12-months post-treatment, 91% of compliant TENT-A2 participants reported continued improvement in their tinnitus symptom severity. To date, there have been three clinical trials completed, involving more than 500 participants, and the research has demonstrated that the Lenire device has clinically shown a reduction in the symptoms of tinnitus. The research papers on Lenire can be found on the Lenire website.

Patient Stories
Lenire Helped Vickie Forgot About Tinnitus
“I think devices like Lenire show that there is hope out there.”
Lenire gave Irina her life back
“I would definitely recommend Lenire to other people. It was basically a lifesaver for me!”
Lenire Helped Dorothy Unwind to Sleep
“Lenire was very easy to use. When I saw it first I was a bit wary but then when I used it, it was very simple.”
Lenire Gave Hugh Control Over His Tinnitus
“After six weeks, I noticed improvement. After another six weeks, I noticed even more improvement. It has changed my mindset.”
Clinical Trial Takeaways
- 83% of 500+ participants across three successful clinical trials would recommend Lenire for the treatment of tinnitus.
- 71% of those with moderate or worse tinnitus had a meaningful reduction in tinnitus severity with Lenire after 6-weeks when 6-weeks of audio-only therapy had minimal impact.
- Zero serious adverse side effects related to Lenire were reported, validating the safety of the device.
- 204 real world patient results closely match clinical trial data.
- One bimodal neuromodulation tinnitus treatment device granted approval by the FDA following a controlled clinical trial – Lenire.